PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD)
C Bergmann, J Senderek, F Küpper… - Human …, 2004 - Wiley Online Library
Autosomal recessive polycystic kidney disease (ARPKD) is an important cause of childhood
renal‐and liver‐related morbidity and mortality. The clinical spectrum is widely variable …
renal‐and liver‐related morbidity and mortality. The clinical spectrum is widely variable …
[HTML][HTML] Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
L Merkens, V Sailer, D Lessel, E Janzen… - Journal of Experimental …, 2022 - Springer
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
S Lim, A Janzer, A Becker, A Zimmer, R Schüle… - …, 2010 - academic.oup.com
Breast carcinogenesis is a multistep process involving both genetic and epigenetic changes.
Since epigenetic changes like histone modifications are potentially reversible processes …
Since epigenetic changes like histone modifications are potentially reversible processes …
Epigenetic regulation of cancer growth by histone demethylases
S Lim, E Metzger, R Schüle, J Kirfel… - International journal of …, 2010 - Wiley Online Library
Cancer is traditionally viewed as a primarily genetic disorder. However, it is now
increasingly apparent that epigenetic abnormalities play a fundamental role in cancer …
increasingly apparent that epigenetic abnormalities play a fundamental role in cancer …
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy
Aberrant epigenetic changes in DNA methylation and histone acetylation are hallmarks of
most cancers, whereas histone methylation was previously considered to be irreversible and …
most cancers, whereas histone methylation was previously considered to be irreversible and …
[HTML][HTML] Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD)
C Bergmann, J Senderek, E Windelen, F Küpper… - Kidney international, 2005 - Elsevier
Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive
polycystic kidney disease (ARPKD). Background ARPKD is associated with mutations in the …
polycystic kidney disease (ARPKD). Background ARPKD is associated with mutations in the …
Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4
E Metzger, A Imhof, D Patel, P Kahl, K Hoffmeyer… - Nature, 2010 - nature.com
Demethylation at distinct lysine residues in histone H3 by lysine-specific demethylase 1
(LSD1) causes either gene repression or activation,. As a component of co-repressor …
(LSD1) causes either gene repression or activation,. As a component of co-repressor …
[HTML][HTML] Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis
R Adam, I Spier, B Zhao, M Kloth, J Marquez… - The American Journal of …, 2016 - cell.com
In∼ 30% of families affected by colorectal adenomatous polyposis, no germline mutations
have been identified in the previously implicated genes APC, MUTYH, POLE, POLD1, and …
have been identified in the previously implicated genes APC, MUTYH, POLE, POLD1, and …
[PDF][PDF] Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy
J Senderek, C Bergmann, C Stendel, J Kirfel… - The American Journal of …, 2003 - cell.com
Charcot-Marie-Tooth disease type 4C (CMT4C) is a childhood-onset demyelinating form of
hereditary motor and sensory neuropathy associated with an early-onset scoliosis and a …
hereditary motor and sensory neuropathy associated with an early-onset scoliosis and a …
[HTML][HTML] Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis
MC Hupe, C Philippi, D Roth, C Kümpers… - Frontiers in …, 2018 - frontiersin.org
Background: Stratifying prostate cancer (PCa) patients into risk groups at time of initial
diagnosis enabling a risk-adapted disease management is still a major clinical challenge …
diagnosis enabling a risk-adapted disease management is still a major clinical challenge …